220 related articles for article (PubMed ID: 25347439)
1. [Simultaneous treatment of HIV and tuberculosis is possible and necessary].
von der Maase S; Gerstoft J; Wejse C
Ugeskr Laeger; 2014 Feb; 176(6A):V03130163. PubMed ID: 25347439
[TBL] [Abstract][Full Text] [Related]
2. Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.
Worodria W; Ssempijja V; Hanrahan C; Ssegonja R; Muhofwa A; Mazapkwe D; Mayanja-Kizza H; Reynolds SJ; Colebunders R; Manabe YC
AIDS; 2018 Sep; 32(15):2141-2149. PubMed ID: 30005014
[TBL] [Abstract][Full Text] [Related]
3. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
Naidoo K; Yende-Zuma N; Padayatchi N; Naidoo K; Jithoo N; Nair G; Bamber S; Gengiah S; El-Sadr WM; Friedland G; Abdool Karim S
Ann Intern Med; 2012 Sep; 157(5):313-24. PubMed ID: 22944873
[TBL] [Abstract][Full Text] [Related]
4. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
[TBL] [Abstract][Full Text] [Related]
5. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.
Uthman OA; Okwundu C; Gbenga K; Volmink J; Dowdy D; Zumla A; Nachega JB
Ann Intern Med; 2015 Jul; 163(1):32-9. PubMed ID: 26148280
[TBL] [Abstract][Full Text] [Related]
6. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
Havlir DV; Kendall MA; Ive P; Kumwenda J; Swindells S; Qasba SS; Luetkemeyer AF; Hogg E; Rooney JF; Wu X; Hosseinipour MC; Lalloo U; Veloso VG; Some FF; Kumarasamy N; Padayatchi N; Santos BR; Reid S; Hakim J; Mohapi L; Mugyenyi P; Sanchez J; Lama JR; Pape JW; Sanchez A; Asmelash A; Moko E; Sawe F; Andersen J; Sanne I;
N Engl J Med; 2011 Oct; 365(16):1482-91. PubMed ID: 22010914
[TBL] [Abstract][Full Text] [Related]
7. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.
Blanc FX; Sok T; Laureillard D; Borand L; Rekacewicz C; Nerrienet E; Madec Y; Marcy O; Chan S; Prak N; Kim C; Lak KK; Hak C; Dim B; Sin CI; Sun S; Guillard B; Sar B; Vong S; Fernandez M; Fox L; Delfraissy JF; Goldfeld AE;
N Engl J Med; 2011 Oct; 365(16):1471-81. PubMed ID: 22010913
[TBL] [Abstract][Full Text] [Related]
8. [Tuberculosis and HIV co-infection: a therapeutic challenge].
Charbonnier F; Calmy A; Janssens JP
Rev Med Suisse; 2011 Nov; 7(318):2295-6, 2298-300. PubMed ID: 22400365
[TBL] [Abstract][Full Text] [Related]
9. Timing of antiretroviral drugs during tuberculosis therapy.
Garcia-Vidal C; Salvado M; Salavert M
N Engl J Med; 2010 Jun; 362(22):2137-8; author reply 2138-9. PubMed ID: 20527080
[No Abstract] [Full Text] [Related]
10. Integration of antiretroviral therapy with tuberculosis treatment.
Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray AL; Gengiah T; Gengiah S; Naidoo A; Jithoo N; Nair G; El-Sadr WM; Friedland G; Abdool Karim Q
N Engl J Med; 2011 Oct; 365(16):1492-501. PubMed ID: 22010915
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of antituberculosis treatments at 18 months follow-up in TB-HIV co-infected patients on ART: a retrospective review of 166 cases.
Chunpongthong P; Ko ZZ; Yeekian C; Luvira V; Pitisuttithum P
J Med Assoc Thai; 2011 Jun; 94(6):664-70. PubMed ID: 21696073
[TBL] [Abstract][Full Text] [Related]
12. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
Meintjes G; Stek C; Blumenthal L; Thienemann F; Schutz C; Buyze J; Ravinetto R; van Loen H; Nair A; Jackson A; Colebunders R; Maartens G; Wilkinson RJ; Lynen L;
N Engl J Med; 2018 Nov; 379(20):1915-1925. PubMed ID: 30428290
[TBL] [Abstract][Full Text] [Related]
13. Timing of initiation of antiretroviral drugs during tuberculosis therapy.
Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray A; Gengiah T; Nair G; Bamber S; Singh A; Khan M; Pienaar J; El-Sadr W; Friedland G; Abdool Karim Q
N Engl J Med; 2010 Feb; 362(8):697-706. PubMed ID: 20181971
[TBL] [Abstract][Full Text] [Related]
14. Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.
Castelnuovo B; Manabe YC; Kiragga A; Kamya M; Easterbrook P; Kambugu A
Clin Infect Dis; 2009 Sep; 49(6):965-72. PubMed ID: 19673615
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors of immune reconstitution inflammatory syndrome in HIV-TB coinfected patients.
Dibyendu D; Sarkar RN; Phaujdar S; Bhattacharyya K; Pal HK
Braz J Infect Dis; 2011; 15(6):553-9. PubMed ID: 22218514
[TBL] [Abstract][Full Text] [Related]
16. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution inflammatory syndrome in an HIV/TB co-infected patient four years after starting antiretroviral therapy.
Huyst V; Lynen L; Bottieau E; Zolfo M; Kestens L; Colebunders R
Acta Clin Belg; 2007; 62(2):126-9. PubMed ID: 17547295
[TBL] [Abstract][Full Text] [Related]
18. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.
Blanc FX; Badje AD; Bonnet M; Gabillard D; Messou E; Muzoora C; Samreth S; Nguyen BD; Borand L; Domergue A; Rapoud D; Natukunda N; Thai S; Juchet S; Eholié SP; Lawn SD; Domoua SK; Anglaret X; Laureillard D;
N Engl J Med; 2020 Jun; 382(25):2397-2410. PubMed ID: 32558469
[TBL] [Abstract][Full Text] [Related]
19. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
Bwire R; Nagelkerke NJ; Borgdorff MW
Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
[TBL] [Abstract][Full Text] [Related]
20. Immune reconstruction inflammatory syndrome in HIV infection: beyond what meets the eye.
Sereti I
Top Antivir Med; 2020 Jan; 27(4):106-111. PubMed ID: 32224502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
